Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for lung cancer].

B Milleron1

  • 1Unité d'Oncologie Pulmonaire, Hôpital Tenon, 4, rue de la Chine, 75020 Paris. bernard.milleron@tnn.ap-hop-paris.fr

Revue De Pneumologie Clinique
|November 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations of French specialists on screening for lung cancer].

Revue des maladies respiratoires·2021
Same author

Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.

HIV medicine·2019
Same author

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

Revue des maladies respiratoires·2018
Same author

[Structuring the French thoracic oncology over the last 20 years].

Revue des maladies respiratoires·2017
Same author

[Current knowledge on perioperative treatments of non-small cell lung carcinomas].

Revue des maladies respiratoires·2017
Same author

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same journal

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Revue de pneumologie clinique·2018
Same journal

[Medical journals publication: Let's change].

Revue de pneumologie clinique·2018
Same journal

[Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

Revue de pneumologie clinique·2018
Same journal

[Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

Revue de pneumologie clinique·2018
Same journal

[Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

Revue de pneumologie clinique·2018
Same journal

[COPD and smoking cessation: Patients' expectations and responses of health professionals].

Revue de pneumologie clinique·2018
See all related articles

Lung cancer screening with low-dose CT scans shows promise for early detection. However, further randomized trials are needed to confirm its impact on lung cancer mortality rates.

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Context:

  • Bronchial cancer is a significant health concern due to its frequency and delayed diagnosis.
  • Early-stage diagnosis is crucial for effective treatment and potential cure.
  • Current screening methods like X-rays and sputum cytology have not definitively proven their effectiveness.

Purpose:

  • To evaluate the potential of screening strategies for bronchial cancer.
  • To assess the efficacy of low-dose computed tomography (CT) scans in early cancer detection.
  • To determine the necessity of further randomized trials for validating screening impacts.

Summary:

  • Bronchial cancer is an ideal candidate for screening due to its severity and delayed diagnosis.
  • Low-dose CT scans demonstrate higher sensitivity than X-rays for detecting early-stage tumors.

Related Experiment Videos

  • However, low-dose CT scans lack specificity, identifying numerous benign abnormalities and potentially leading to unnecessary procedures.

    • Impact:

    • The effectiveness of X-ray and sputum cytology in lung cancer screening remains unproven despite numerous trials.
    • Low-dose CT scans offer improved sensitivity for early tumor detection but require further validation.
    • Randomized trials are essential to demonstrate the impact of low-dose CT screening on lung cancer mortality.